Calian’s Contract Research Organization, part of Calian Group (TSX: CGY), delivers comprehensive Phase I–IV clinical trial, monitoring, and data services across diverse therapeutic areas. With patient-centric decentralized trial platforms and a reputation for excellence—as evidenced by its inclusion in TIME and Forbes employer rankings—the CRO arm is a trusted partner in Canada’s clinical research landscape and has been an N2 Canada member since 2019.